KLOW

Research Use Only

All products are intended solely for laboratory research and are not for human or animal consumption. These products are not drugs, foods, or cosmetics, and are not intended to diagnose, treat, cure, or prevent any disease. Purchasers must be 21 years or older. By purchasing, the buyer agrees to use these products in compliance with all applicable laws and regulations.

KLOW Blend Overview

The KLOW Blend combines GHK-Cu, BPC-157, TB-500, and KPV into a single formulation studied for its potential influence on molecular signaling and systemic regulation. In laboratory and preclinical models, these peptides have been investigated for their effects on matrix remodeling, angiogenesis, cytokine modulation, and extracellular matrix activity. Together, they provide a platform for exploring pathways in molecular dynamics, immune signaling, and vascular biology.

History

The KLOW Blend draws on several decades of peptide research. GHK-Cu, first identified in human plasma in the 1970s, has been studied for gene expression and matrix signaling. BPC-157, characterized in the 1990s as a gastric protein fragment, has been explored for angiogenic and structural processes. TB-500, derived from thymosin beta-4 research, has been examined for angiogenesis and molecular migration. KPV, a C-terminal fragment of α-MSH, has been evaluated for cytokine-modulating and immunomodulatory activity. Collectively, these peptides represent areas of ongoing investigation into experimental biology, vascular pathways, and immune signaling.

GHK-Cu Structure

Molecular Formula: C₁₄H₂₄CuN₆O₄
Molecular Weight: ~403.9 g/mol
CAS: 49557-75-7

BPC-157 Structure

Molecular Formula: C₆₂H₉₈N₁₆O₂₂
Molecular Weight: 1419.5 g/mol
CAS: 137525-51-0

TB-500 Structure

Molecular Formula: C₂₁₂H₃₅₀N₅₆O₇₈S
Molecular Weight: 4963.5 g/mol
CAS: 77591-33-4

KPV Structure

Molecular Formula: C₁₆H₃₀N₄O₄
Molecular Weight: 342.43 g/mol
CAS: 67727-97-3

Research Findings

The KLOW Blend, which combines GHK-Cu, BPC-157, TB-500, and KPV, has been studied in structural, vascular, epithelial, and systemic models. Research highlights activity in collagen formation, extracellular matrix remodeling, angiogenesis, molecular migration, and cytokine modulation. The inclusion of KPV further supports immune signaling and cytokine-modulating pathways, expanding the experimental scope of this blend in preclinical settings.

Key Areas of Research:

• Structural: Collagen, matrix, connective signaling
• Vascular: Angiogenesis, nitric oxide, remodeling
• Epithelial: Migration, matrix signaling, follicle dynamics
• Systemic: Cytokine modulation, immune signaling, pathway dynamics

Together, these findings suggest broad experimental potential for the KLOW Blend across multiple biological pathways. By combining structural support, vascular and epithelial activity, and immune signaling, the KLOW Blend provides a versatile platform for research into molecular dynamics, matrix characterization, and systemic resilience in laboratory settings.

References

Maquart, F.X., Pickart, L., Laurent, M., et al. (1988). Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu²⁺. FEBS Letters, 238(2), 343–346.

Pickart, L., & Margolina, A. (2018). Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. International Journal of Molecular Sciences, 19(7), 1987.

Sikirić, P., et al. (1993). A new gastric juice peptide, BPC. An overview of the stomach-stress-organoprotection hypothesis and beneficial effects of BPC. Journal of Physiology (Paris), 87(5), 313–327.

Chang, C.H., et al. (2011). The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. Journal of Applied Physiology, 110(3), 774–780.

Smart, N., et al. (2007). Thymosin β4 induces adult epicardial progenitor mobilization and neovascularization. Nature, 445(7124), 177–182.

Philp, D., et al. (2003). Thymosin β4 and a synthetic peptide containing its actin-binding domain promote dermal wound repair. Wound Repair and Regeneration, 11(1), 19–24.

Dalmasso, G., et al. (2008). PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology, 134(1), 166–178.

Brzoska, T., et al. (2008). Alpha-melanocyte-stimulating hormone and related tripeptides: biochemistry, antiinflammatory and protective effects in vitro and in vivo. Endocrine Reviews, 29(5), 581–602.